Form 8-K - Current report:
SEC Accession No. 0001193125-25-146905
Filing Date
2025-06-25
Accepted
2025-06-25 16:13:09
Documents
14
Period of Report
2025-06-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d32006d8k.htm   iXBRL 8-K 39299
2 EX-10.1 d32006dex101.htm EX-10.1 225065
3 EX-99.1 d32006dex991.htm EX-99.1 10324
  Complete submission text file 0001193125-25-146905.txt   451754

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrvi-20250622.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrvi-20250622_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrvi-20250622_pre.xml EX-101.PRE 11262
16 EXTRACTED XBRL INSTANCE DOCUMENT d32006d8k_htm.xml XML 3656
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 251073771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)